Healthy Beginnings

Beat Cancer with this New Non-Toxic Treatment

A new and exciting development in the field of cancer!

A new and exciting development in the field of cancer! treatment!

Salicinium, a glycome (complex sugar molecule), does not actually kill the cancer cell. It enters into a metabolic reaction that shuts down the ability of the cancer cell to hide from the immune system. An active immune system then can recognize the cancer cell as abnormal and kill it without harming any normal cells.

In 1931, a German physician and scientist received a Nobel Prize for proving that all cancer cells primarily use a very primitive method of producing energy from sugar. It is called anaerobic metabolism (or glycolysis). This is actually a form of fermentation. It takes place in the liquid part of the cell called the cytoplasm, without the use of oxygen.

A person forms cancer for only one reason–a lack of sufficient oxygen to a certain subset of the 210 different types of cells known to make up the human body. This is called hypoxia. There are many things that can cause this hypoxia. In order to survive and keep producing energy, those cells must switch over to glycolysis as a source of their energy. At exactly the same time as fermentation starts, the now sickened, dysfunctional cells must also start protecting itself from the immune system. They do this by producing an enzyme called alpha-N-acetylgalactosaminidase, or for short, nagalase.

Nagalase has the ability to completely shut down the localized immune macrophage cell, whose job is to destroy any cell that has been harmed or is not functioning normally. It effectively “cloaks” the cancer cells from detection by the immune system. This is the reason that someone can have a strong functioning immune system and still be growing a tumor.

Salicinium is a glycome (complex sugar) molecule. The malignant cell sees sugar passing by in the bloodstream, invites it in, and very quickly another enzyme found only in fermenting cells (beta glucosidase) splits the sugar part off from the complex molecule. The non-glycome part of the molecule, when released, attaches to a part of the cells’ energy producing apparatus. This causes the cells to cease production of nagalase.

With stopping production of nagalase, the macrophage cells can resume their function, which was “turned off” by the cancer cells and can now recognize the sick, unprotected, dysfunctional cell and dispose of it as they would any other cells that are at the end of their life cycle. Salicinium has simply removed the cloak, allowing the body’s own natural immune response to work as it should.

Salicinium does not “kill” or “cure” fermenting cells-only the immune system can do that. Through the use of Salicinium, however, the immune system is returned to a functional state. Since Salicinium is a complex sugar, it is harmless to any normal cell in the body because a normal cell cannot assimilate complex glycomes.

Since it is a complex sugar, and normal (aerobic-oxygen using) cells have no b-Glycosidase enzyme to split the sugar off the molecule, healthy cells cannot assimilate it and do not absorb Salicinium. It is harmless to any normal cell in the body.

Salicinium is a prospective adjunct to orthodox chemotherapy as neither interferes with the function of the other, however, by using Salicinium, the dosage of the chemotherapy can be reduced to a fractionated (10-15 percent) of the full dose. This is especially true when the chemo drugs are administered in the setting of Insulin Potentiated Therapy (IPT).

This is an exciting new development in the field of cancer treatment!

1. Eslinger, Robert A., D.O., H.M.D., Townsend Letter, August/September 2013, 86-89
2. Yamamoto N., Suyama H, Immunotherapy for prostate cancer with Gc protein derived macrophage activating factor, Transl Oncol, 2008; 1:65-72.

For more info, contact Reno Integrative Medical Center at (775) 829-1009, or visit online at